Clarius Group, LLC
- SEC CIK
- 0001664214
- Latest filing
- Jan 14, 2026
LYEL holding history
Lyell Immunopharma, Inc. in every 13F filed by Clarius Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LYEL overviewAll 13F holders of LYELFull Q4 2025 holdings
- Shares (Q4 2025)
- 19,958
- Value
- $614.3K
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 19,958 | $614.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 19,958 | $324.1K | <0.1% | +820+4.3% | Added | Holders |
| Q2 2025 | 19,138 | $169.2K | <0.1% | −820−4.1% | ReducedConverted for a 1-for-20 split | Holders |
| Q1 2025 | 399,168 | $214.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 399,168 | $255.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 399,168 | $550.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 399,168 | $578.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 399,168 | $890.1K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 399,168 | $774.4K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 399,168 | $586.8K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 399,168 | $1.27M | 0.1% | +382,764+2,333.4% | Added | Holders |
| Q1 2023 | 16,404 | $38.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 16,404 | $57.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 16,404 | $120.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 16,404 | $107.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 16,404 | $127.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 16,404 | $127.0K | <0.1% | +16,404 | New | Holders |